Similar to Ela-myc pancreatic tumors in vivo, these cells expressed the sunitinib-targeted RTKs VEGFR2, PDGFR-α and PDGFR-β (Figure 5A). This evidence concerns the gene PDGFRA and pancreatic neoplasm.